CACI International (NYSE:CACI – Get Free Report) issued an update on its FY25 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $22.89-23.78 for the period, compared to the consensus earnings per share estimate of $23.20. The company issued revenue guidance of $8.1-8.3 billion, compared to the consensus revenue estimate of $8.09 billion. CACI International also updated its FY 2025 guidance to 22.890-23.780 EPS.
CACI International Stock Performance
CACI International stock traded down $2.86 during mid-day trading on Friday, reaching $549.69. The company’s stock had a trading volume of 75,816 shares, compared to its average volume of 111,924. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.42. CACI International has a twelve month low of $302.21 and a twelve month high of $570.28. The business has a 50 day moving average price of $495.16 and a 200-day moving average price of $449.05. The firm has a market cap of $12.26 billion, a price-to-earnings ratio of 31.85, a PEG ratio of 2.22 and a beta of 0.93.
CACI International (NYSE:CACI – Get Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The information technology services provider reported $5.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.08 by $0.85. CACI International had a return on equity of 14.31% and a net margin of 5.48%. The business had revenue of $2.06 billion for the quarter, compared to the consensus estimate of $1.92 billion. During the same quarter last year, the business posted $4.36 EPS. The business’s revenue was up 11.2% on a year-over-year basis. Sell-side analysts predict that CACI International will post 23 EPS for the current fiscal year.
Wall Street Analyst Weigh In
View Our Latest Analysis on CACI International
Insider Buying and Selling
In other CACI International news, Director Gregory G. Johnson sold 300 shares of the stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $471.00, for a total transaction of $141,300.00. Following the transaction, the director now owns 5,910 shares in the company, valued at $2,783,610. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, Director Gregory G. Johnson sold 300 shares of the business’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $471.00, for a total transaction of $141,300.00. Following the completion of the transaction, the director now owns 5,910 shares of the company’s stock, valued at approximately $2,783,610. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Gregory R. Bradford sold 10,000 shares of the stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of $492.41, for a total value of $4,924,100.00. Following the completion of the sale, the insider now directly owns 35,538 shares of the company’s stock, valued at $17,499,266.58. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 21,270 shares of company stock worth $10,165,972. Corporate insiders own 1.23% of the company’s stock.
About CACI International
CACI International Inc, through its subsidiaries, engages in the provision of expertise and technology to enterprise and mission customers in support of national security in the intelligence, defense, and federal civilian sectors. The company operates through two segments, Domestic Operations and International Operations.
Further Reading
- Five stocks we like better than CACI International
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Texas Roadhouse Stock Steering for New Highs This Year
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for CACI International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CACI International and related companies with MarketBeat.com's FREE daily email newsletter.